|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Lung and Thoracic cancer
Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable
EGFR
-Mutant Non–Small Cell Lung Cancer
Beung-Chul Ahn, Charny Park, Moon Soo Kim, Jong Mog Lee, Jin Ho Choi, Hyae Young Kim, Geon Kook Lee, Namhee Yu, Youngjoo Lee, Ji-Youn Han
Cancer Res Treat.
2024;56(1):70-80. Published online June 21, 2023 DOI:
https://doi.org/10.4143/crt.2023.482
General
Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers
Jae Sik Kim, Joo Ho Lee, Sang-Rok Jeon, Yongsub Kim, Seung Hyuck Jeon, Hong-Gyun Wu
Cancer Res Treat.
2023;55(3):737-745. Published online January 4, 2023 DOI:
https://doi.org/10.4143/crt.2022.1414
Crossref 1
Breast cancer
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens
Helen P. Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, Anna Batistatou, Kyriaki Papadopoulou, Mattheos Bobos, Anthoula Asimaki-Vlachopoulou, Sofia Chrisafi, Kitty Pavlakis, Kyriakos Chatzopoulos, Eleni Galani, George Pentheroudakis, Dimitrios Pectasides, Dimitrios Bafaloukos, Eleni Res, Pavlos Papakostas, Angelos Koutras, Vassiliki Kotoula, George Fountzilas
Cancer Res Treat.
2022;54(4):1053-1064. Published online November 17, 2021 DOI:
https://doi.org/10.4143/crt.2021.748
Web of Science 2
Crossref 1
Lung and Thoracic cancer
miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non-Small Cell Lung Cancer Cells by Targeting USP37
Mi Seong Kim, So Hui Kim, Sei Hoon Yang, Min Seuk Kim
Cancer Res Treat.
2022;54(2):445-457. Published online August 3, 2021 DOI:
https://doi.org/10.4143/crt.2021.622
Web of Science 5
Crossref 3
Endocrine cancer
Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea
Hwa Young Ahn, Ra-Yeong Song, Hye Shin Ahn, Hee Sung Kim
Cancer Res Treat.
2021;53(4):1204-1212. Published online February 10, 2021 DOI:
https://doi.org/10.4143/crt.2020.1201
Web of Science 3
Crossref 3
Gastrointestinal cancer
Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the
Growth
and Migration of Hepatoma Cells
Fanyun Kong, Yukai Tao, Dongchen Yuan, Ning Zhang, Qi Li, Tong Yu, Xiaoying Yang, Delong Kong, Xiaohui Ding, Xiangye Liu, Hongjuan You, Kuiyang Zheng, Renxian Tang
Cancer Res Treat.
2021;53(2):506-527. Published online November 16, 2020 DOI:
https://doi.org/10.4143/crt.2020.397
Crossref 7
FGFR4
Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition
Yanwei Ye, Jie Li, Dongbao Jiang, Jingjing Li, Chuangfeng Xiao, Yingze Li, Chao Han, Chunlin Zhao
Cancer Res Treat.
2020;52(4):1162-1177. Published online May 25, 2020 DOI:
https://doi.org/10.4143/crt.2020.138
Web of Science 4
Crossref 3
Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
Eunhyang Park, Hyo Sup Shim
Cancer Res Treat.
2020;52(2):543-551. Published online November 8, 2019 DOI:
https://doi.org/10.4143/crt.2019.305
Web of Science 15
Crossref 13
Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
Myung-Ju Ahn, Ji-Youn Han, Dong-Wan Kim, Byoung Chul Cho, Jin-Hyoung Kang, Sang-We Kim, James Chih-Hsin Yang, Tetsuya Mitsudomi, Jong Seok Lee
Cancer Res Treat.
2020;52(1):284-291. Published online July 23, 2019 DOI:
https://doi.org/10.4143/crt.2019.200
Web of Science 5
Crossref 4
Fibroblast
Growth
Factor Receptor 1 (
FGFR1
) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
Jeong Mo Bae, Xianyu Wen, Tae-Shin Kim, Yoonjin Kwak, Nam-Yun Cho, Hye Seung Lee, Gyeong Hoon Kang
Cancer Res Treat.
2020;52(1):74-84. Published online May 8, 2019 DOI:
https://doi.org/10.4143/crt.2019.062
Web of Science 14
Crossref 15
Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014
Chang-Min Choi, Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Yoo-Duk Choi, Yang-Gun Suh, Jung-Eun Kim, Boram Lee, Young-Joo Won, Young-Chul Kim
Cancer Res Treat.
2019;51(4):1400-1410. Published online February 25, 2019 DOI:
https://doi.org/10.4143/crt.2018.704
Web of Science 45
Crossref 43
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal
Growth
Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, Ki Hyeong Lee, Keon Uk Park, Ki Hwan Kim, Eun Kyung Cho, Yoon Hee Choi, Hye Ryun Kim, Hoon-Gu Kim, Heui June Ahn, Ha Yeon Lee, Hwan Jung Yun, Jin-Hyoung Kang, Jaeheon Jeong, Moon Young Choi, Sin-Ho Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.
2019;51(2):718-726. Published online September 3, 2018 DOI:
https://doi.org/10.4143/crt.2018.324
Web of Science 10
Crossref 10
Clinical Outcomes of
EGFR
Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
Seonggyu Byeon, Youjin Kim, Sung Won Lim, Jang Ho Cho, Sehoon Park, Jiyun Lee, Jong-Mu Sun, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.
2019;51(2):623-631. Published online July 23, 2018 DOI:
https://doi.org/10.4143/crt.2018.151
Web of Science 41
Crossref 34
Efficacy and Safety of Afatinib for
EGFR
-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Youjin Kim, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Cancer Res Treat.
2019;51(2):502-509. Published online June 13, 2018 DOI:
https://doi.org/10.4143/crt.2018.117
Web of Science 69
Crossref 57
Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway
Jianhui Cai, Limin Xia, Jinlei Li, Shichang Ni, Huayu Song, Xiangbin Wu
Cancer Res Treat.
2019;51(1):252-266. Published online April 25, 2018 DOI:
https://doi.org/10.4143/crt.2017.613
Web of Science 69
Crossref 68
The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
Ji Young Choi, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Seong Jin Jo
Cancer Res Treat.
2019;51(1):169-177. Published online April 5, 2018 DOI:
https://doi.org/10.4143/crt.2017.491
Web of Science 3
Crossref 4
Impact of Pulmonary Tuberculosis on the
EGFR
Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
In Kyoung Hwang, Seung Sook Paik, Seung Hyeun Lee
Cancer Res Treat.
2019;51(1):158-168. Published online April 2, 2018 DOI:
https://doi.org/10.4143/crt.2018.084
Web of Science 15
Crossref 13
Ligand-Independent Epidermal
Growth
Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
Sumi Yun, Yoonjin Kwak, Soo Kyung Nam, An Na Seo, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee
Cancer Res Treat.
2018;50(4):1351-1361. Published online January 17, 2018 DOI:
https://doi.org/10.4143/crt.2017.487
Web of Science 12
Crossref 11
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal
Growth
Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Kun-Chieh Chen, Chia-Hung Hsu, Kang-Yi Su, Jeremy J. W. Chen, Huei-Wen Chen, Sung-Liang Yu, Tsung-Ying Yang, Gee-Chen Chang
Cancer Res Treat.
2018;50(4):1294-1303. Published online January 4, 2018 DOI:
https://doi.org/10.4143/crt.2017.512
Web of Science 46
Crossref 43
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Yen-Hsiang Huang, Kang-Yi Su, Sung-Liang Yu, Gee-Chen Chang
Cancer Res Treat.
2018;50(4):1164-1174. Published online December 11, 2017 DOI:
https://doi.org/10.4143/crt.2017.460
Web of Science 5
Crossref 3
EGFR
Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
Jiyoul Yang, Ok-Jun Lee, Seung-Myoung Son, Chang Gok Woo, Yusook Jeong, Yaewon Yang, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han
Cancer Res Treat.
2018;50(3):908-916. Published online September 19, 2017 DOI:
https://doi.org/10.4143/crt.2017.378
Web of Science 31
Crossref 25
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with
EGFR
-Mutant Non-small Cell Lung Cancer
Jong Ho Cho, Wei Zhou, Yoon-La Choi, Jong-Mu Sun, Hyejoo Choi, Tae-Eun Kim, Marisa Dolled-Filhart, Kenneth Emancipator, Mary Anne Rutkowski, Jhingook Kim
Cancer Res Treat.
2018;50(1):95-102. Published online March 17, 2017 DOI:
https://doi.org/10.4143/crt.2016.591
Web of Science 21
Crossref 17
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study
Keunchil Park, Eun Kyung Cho, Maximino Bello, Myung-Ju Ahn, Sumitra Thongprasert, Eun-Kee Song, Victoria Soldatenkova, Henrik Depenbrock, Tarun Puri, Mauro Orlando
Cancer Res Treat.
2017;49(4):937-946. Published online January 6, 2017 DOI:
https://doi.org/10.4143/crt.2016.423
Web of Science 8
Crossref 5
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang
Cancer Res Treat.
2017;49(4):851-868. Published online January 3, 2017 DOI:
https://doi.org/10.4143/crt.2016.176
Web of Science 43
Crossref 38
A Phase II Study of Poziotinib in Patients with Epidermal
Growth
Factor Receptor (
EGFR
)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors
Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Young Joo Min, Eunkyung Cho, Youngjoo Lee, Soo-Hyun Lee, Hyae Young Kim, Geon Kook Lee, Byung Ho Nam, Hyesun Han, Jina Jung, Jin Soo Lee
Cancer Res Treat.
2017;49(1):10-19. Published online May 3, 2016 DOI:
https://doi.org/10.4143/crt.2016.058
Web of Science 35
Crossref 33
Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
Vivek Narayan, Ronac Mamtani, Stephen Keefe, Thomas Guzzo, S. Bruce Malkowicz, David J. Vaughn
Cancer Res Treat.
2016;48(3):1084-1091. Published online December 2, 2015 DOI:
https://doi.org/10.4143/crt.2015.405
Web of Science 13
Crossref 12
Efficacy of Imatinib in Patients with Platelet-Derived
Growth
Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors
Changhoon Yoo, Min-Hee Ryu, Jungmin Jo, Inkeun Park, Baek-Yeol Ryoo, Yoon-Koo Kang
Cancer Res Treat.
2016;48(2):546-552. Published online June 22, 2015 DOI:
https://doi.org/10.4143/crt.2015.015
Web of Science 36
Crossref 31
VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
Seongyeol Park, Soo Jeong Nam, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, J. Hun Hah, Tack-Kyun Kwon, Dong-Wan Kim, Myung-Whun Sung, Dae Seog Heo, Yung-Jue Bang
Cancer Res Treat.
2016;48(2):518-526. Published online July 14, 2015 DOI:
https://doi.org/10.4143/crt.2015.093
Web of Science 26
Crossref 23
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A
Post Hoc
Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
Jin Hyoung Kang, Myung-Ju Ahn, Dong-Wan Kim, Eun Kyung Cho, Joo-Hang Kim, Sang Won Shin, Xin Wang, Jong Seok Kim, Mauro Orlando, Keunchil Park
Cancer Res Treat.
2016;48(2):458-464. Published online October 14, 2015 DOI:
https://doi.org/10.4143/crt.2015.135
Web of Science 1
Crossref 1
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
Young Saing Kim, Eun Kyung Cho, Hyun Sun Woo, Junshik Hong, Hee Kyung Ahn, Inkeun Park, Sun Jin Sym, Sun Young Kyung, Shin Myung Kang, Jeong-Woong Park, Sung Hwan Jeong, Jinny Park, Jae Hoon Lee, Dong Bok Shin
Cancer Res Treat.
2016;48(1):80-87. Published online March 2, 2015 DOI:
https://doi.org/10.4143/crt.2014.307
Web of Science 15
Crossref 8
1
2
3
Journal Impact Factor 4.6